Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Ophthalmology. 2016 Nov 30;124(4):424–430. doi: 10.1016/j.ophtha.2016.10.031

Table 1.

Characteristics of Study Sample

Diabetes Mellitus
T1DM
N=2240
T2DM
N=1768

Median (25 percentile, 75th percentile) Median (25th percentile, 75th percentile

Age at initial diabetes diagnosis (years) 12 (8,15)  18 (16, 21) 
Years of follow-up after initial diabetes diagnosis 3.2 (1.8, 5.4) 3.1 (1.9, 4.9)
HbA1ca 6.6 (5.6, 8.1) 5.6 (5.4, 6.4)

N % N %

Female 1066 47.6% 1468 83.0%
Race
 White 1907 85.1% 1278 72.3%
 Black 157 7.0%   206 11.7%
 Latino 131 5.9%   214 12.1%
 Asian 45 2.1%   70 4.0%  
Household Net Worth
 <$25,000 227 10.1% 350 15.4%
 $25,000–$149,999 490 7.5%   411 10.8%
 $150,000–$249,999 359 11.2% 235 12.0%
 $250,000–$499,999 641 51.9% 403 43.8%
 ≥$500,000 523 19.3% 369 18.1%
Diabetic Retinopathy 451 20.1% 127 7.2%  
 Proliferative Diabetic Retinopathy 12 0.5%   1 0.1%  
 Nonproliferative Diabetic Retinopathy 21 1.0%   6 0.3%  
 Diabetic Macular Edemab 5 0.2%   0 0.0%  
 Nonspecific diabetic retinopathy 418 18.7% 120 6.8%  

T1DM=Type 1 diabetes mellitus. T2DM = Type 2 diabetes mellitus. HbA1c = Glycosylated hemoglobin

a

HbA1c was available only for a subset of patients (N=594 for T1DM, N=389 for T2DM)

b

Some patients with diabetic macular edema also had other codes for diabetic retinopathy